National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

suberoylanilide hydroxamic acid (SOO-ber-oyl-AN-ih-lide hy-drok-SA-mik A-sid)

 A drug that is used to treat cutaneous T-cell lymphoma that does not get better, gets worse, or comes back during or after treatment with other drugs. It is also being studied in the treatment of other types of cancer. Suberoylanilide hydroxamic acid is a type of histone deacetylase inhibitor. Also called SAHA, vorinostat, and Zolinza.



Previous Definitions:SU5416, SU6668, subcutaneous, subcutaneous port, subependymal
Next Definitions:subglottis, subjective improvement, submucosa, subserosa, subset analysis

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov